Skip to main content
Livermore
Livermore
ZHEN

Redmile Group, LLC

SEC CIK
0001425738
Latest filing
Aug 14, 2026

XERS holding history

Xeris Biopharma Holdings, Inc. in every 13F filed by Redmile Group, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

XERS overviewAll 13F holders of XERSFull Q2 2026 holdings

Shares (Q4 2025)
0
Sold out in Q4 2025
Value
$0
% of portfolio
0.0%
Quarters held
19
Since Q1 2021
Holdings of XERS by Redmile Group, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 20250$00.0%−451,099−100.0%Sold outHolders
Q3 2025451,099$3.67M0.4%00.0%UnchangedHolders
Q2 2025451,099$2.11M0.2%00.0%UnchangedHolders
Q1 2025451,099$2.48M0.2%00.0%UnchangedHolders
Q4 2024451,099$1.53M0.1%−595,488−56.9%ReducedHolders
Q3 20241,046,587$2.98M0.2%00.0%UnchangedHolders
Q2 20241,046,587$2.35M0.1%00.0%UnchangedHolders
Q1 20241,046,587$2.31M0.1%00.0%UnchangedHolders
Q4 20231,046,587$2.46M0.1%00.0%UnchangedHolders
Q3 20231,046,587$1.95M0.1%00.0%UnchangedHolders
Q2 20231,046,587$2.74M0.1%00.0%UnchangedHolders
Q1 20231,046,587$1.71M0.1%00.0%UnchangedHolders
Q4 20221,046,587$1.39M0.1%00.0%UnchangedHolders
Q3 20221,046,587$1.63M0.1%00.0%UnchangedHolders
Q2 20221,046,587$1.61M0.1%00.0%UnchangedHolders
Q1 20221,046,587$2.68M0.1%00.0%UnchangedHolders
Q4 20211,046,587$3.07M0.1%−312,238−23.0%ReducedHolders
Q3 20211,358,825$3.33M0.1%00.0%UnchangedHolders
Q2 20211,358,825$5.53M0.1%−353,479−20.6%ReducedHolders
Q1 20211,712,304$7.72M0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.